Page last updated: 2024-12-10

4-nitrophenylhydrazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-nitrophenylhydrazine: reagent for ketones, aliphatic aldehydes; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-nitrophenylhydrazine : A member of the class of phenylhydrazines that is phenylhydrazine substituted at the 4-position by a nitro group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3310889
CHEBI ID66931
SCHEMBL ID316179
MeSH IDM0046768

Synonyms (48)

Synonym
BB 0240531
hydrazine,(p-nitrophenyl)-
hydrazine, (4-nitrophenyl)-
100-16-3
nsc4079
wln: zmr dnw
nsc-4079
hydrazine, (p-nitrophenyl)-
(p-nitrophenyl)hydrazine
p-hydrazinonitrobenzene
(4-nitrophenyl)hydrazine
einecs 202-824-8
brn 0608107
nsc 4079
ccris 3139
4-nitrophenylhydrazine
ai3-08827
p-nitrophenylhydrazine
inchi=1/c6h7n3o2/c7-8-5-1-3-6(4-2-5)9(10)11/h1-4,8h,7h
4-nitrophenylhydrazine, 96%
N-4470
AKOS000119065
unii-2i8586432k
4-15-00-00317 (beilstein handbook reference)
2i8586432k ,
N0230
CHEBI:66931
BP-20431
FT-0619282
PS-4173
1-(4-nitrophenyl)hydrazine
hydrazine, (p-nitrophenyl)
p-hydrazinonitrobenz
(4-nitrophenyl)hydrazine [mi]
SCHEMBL316179
DTXSID4059207
4-nitrophenyl hydrazine
4-nitrophenyl-hydrazine
p-nitrophenylhydrazide
p-nitrophenyl hydrazine
1-(4-nitrophenyl)hydrazine #
F0001-0009
p-nitrophenylhydrazin
Q3599058
AM9760
4-nitro phenyl hydrazine
(4-nitro-phenyl)-hydrazine
EN300-19018
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mutagenAn agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
phenylhydrazinesAny member of the class of hydrazines carrying a phenyl substituent.
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (15.38)18.7374
1990's7 (53.85)18.2507
2000's2 (15.38)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 69.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index69.84 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index113.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (69.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]